Extracellular Nucleotide Metabolism and Signaling in the Pathophysiology of Articular Cartilage

Arthritis and Rheumatism

Volumn 48, Issue 10, 2003, Pages 2722-2736

  Picher, Maryse ^a   Graff, Ronald D ^a   Lee, Greta M ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE RECEPTOR; ADENOSINE TRIPHOSPHATE; CALCIUM 45; CALCIUM PYROPHOSPHATE; CYTOKINE; GROWTH FACTOR; HYDROXYAPATITE; INTERLEUKIN 1BETA; MESSENGER RNA; NUCLEOTIDASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN KINASE; PURINE P2 RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; URIC ACID;

ANIMAL CELL; ARTHRITIS; ARTICULAR CARTILAGE; CARTILAGE CELL; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GOUT; HUMAN; HUMAN CELL; MEMBRANE TRANSPORT; NONHUMAN; NUCLEOTIDE METABOLISM; OSTEOARTHRITIS; PRIORITY JOURNAL; PSEUDOGOUT; REVIEW; SYNOVIAL FLUID;

ADENINE NUCLEOTIDES; ANIMALS; CARTILAGE, ARTICULAR; EXTRACELLULAR FLUID; HUMANS; OSTEOARTHRITIS; SIGNAL TRANSDUCTION;

EID: 0142135854     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.11289     Document Type: Review

References (189)

1. Felson DT, Lawrence RC, Dieppe PA, Hirsch R, Helmick CG, Jordan JM, et al. Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med 2000;133:635-46.
2. Sandell LJ, Aigner T. Articular cartilage and changes in arthritis. An introduction: cell biology of osteoarthritis. Arthritis Res 2001;3:107-13.
3. Terkeltaub RA. What does cartilage calcification tell us about osteoarthritis? J Rheumatol 2002;29:411-5.
4. Timms AE, Zhang Y, Russell RG, Brown MA. Genetic studies of disorders of calcium crystal deposition. Rheumatology (Oxford) 2002;41:725-9.
5. Rosenthal AK, Ryan LM. Calcium pyrophosphate crystal deposition disease, pseudogout, and articular chondrocalcinosis. In: Koopman WJ, editor. Arthritis and allied conditions. A textbook of rheumatology. Vol. 2. 14th ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 2348-71.
6. Halverson PB. Basic calcium phosphate (apatite, octacalcium phosphate, tricalcium phosphate) crystal deposition diseases and calcinosis. In: Koopman WJ, editor. Arthritis and allied conditions. A textbook of rheumatology. Vol. 2. 14th ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 2372-92.
7. Derfus BA, Kurian JB, Butler JJ, Daft LJ, Carrera GF, Ryan LM, et al. The high prevalence of pathologic calcium crystals in pre-operative knees. J Rheumatol 2002;29:570-4.
8. Reuge L, van Linthoudt D, Gerster JC. Local deposition of calcium pyrophosphate crystals in evolution of knee osteoarthritis. Clin Rheumatol 2001;20:428-31.
9. Nalbant S, Martinez JA, Kitumnuaypong T, Clayburne G, Sieck M, Schumacher HR Jr. Synovial fluid features and their relations to osteoarthritis severity: new findings from sequential studies. Osteoarthritis Cartilage 2003;11:50-4.
10. Russell RG, Muhlbauer RC, Bisaz S, Williams DA, Fleisch H. The influence of pyrophosphate, condensed phosphates, phosphonates and other phosphate compounds on the dissolution of hydroxyapatite in vitro and on bone resorption induced by parathyroid hormone in tissue culture and in thyroparathyroidectomised rats. Calcif Tissue Res 1970;6:183-96.
11. Siegel SA, Hummel CF, Carty RP. The role of nucleoside triphosphate pyrophosphohydrolase in in vitro nucleoside triphosphate-dependent matrix vesicle calcification. J Biol Chem 1983;258:8601-7.
12. Ryan LM, McCarty DJ. Calcium pyrophosphate crystal deposition disease, pseudogout, and articular chondrocalcinosis. In: Koopman W, editor. Arthritis and allied conditions. A textbook of rheumatology. 13th ed. Baltimore: Williams & Wilkins; 1997. p. 2103-26.
13. Terkeltaub RA. Inorganic pyrophosphate generation and disposition in pathophysiology. Am J Physiol 2001;281:C1-11.
14. Okawa A, Nakamura I, Goto S, Moriya H, Nakamura Y, Ikegawa S. Mutation in Npps in a mouse model of ossification of the posterior longitudinal ligament of the spine. Nat Genet 1998;19:271-3.
15. Bollen M, Gijsbers R, Ceulemans H, Stalmans W, Stefan C. Nucleotide pyrophosphatases/phosphodiesterases on the move. Crit Rev Biochem Mol Biol 2000;35:393-432.
16. Nakamura I, Ikegawa S, Okawa A, Okuda S, Koshizuka Y, Kawaguchi H, et al. Association of the human NPPS gene with ossification of the posterior longitudinal ligament of the spine (OPLL). Hum Genet 1999;104:492-7.
17. Pendleton A, Johnson MD, Hughes A, Gurley KA, Ho AM, Doherty M, et al. Mutations in ANKH cause chondrocalcinosis. Am J Hum Genet 2002;71:933-40.
18. Ho AM, Johnson MD, Kingsley DM. Role of the mouse ank gene in control of tissue calcification and arthritis. Science 2000;289:265-70.
19. Nurnberg P, Thiele H, Chandler D, Hohne W, Cunningham ML, Ritter H, et al. Heterozygous mutations in ANKH, the human ortholog of the mouse progressive ankylosis gene, result in craniometaphyseal dysplasia. Nat Genet 2001;28:37-41.
20. Hatori M, Teixeira CC, Debolt K, Pacifici M, Shapiro IM. Adenine nucleotide metabolism by chondrocytes in vitro: role of ATP in chondrocyte maturation and matrix mineralization. J Cell Physiol 1995;165:468-74.
21. Lazarowski ER, Boucher RC, Harden TK. Constitutive release of ATP and evidence for major contribution of ecto-nucleotide pyrophosphatase and nucleoside diphosphokinase to extracellular nucleotide concentrations. J Biol Chem 2000;275:31061-8.
22. Graff RD, Lazarowski ER, Lee GM. Interconversion of extracellular nucleotides by ectonucleoside diphosphokinase on porcine articular chondrocytes [abstract]. Trans Orthop Res Soc 2001;26:405.
23. Graff RD, Lazarowski ER, Banes AJ, Lee GM. ATP release by mechanically loaded porcine chondrons in pellet culture. Arthritis Rheum 2000;43:1571-9.
24. Ryan LM, Kurup IV, Derfus BA, Kushnaryov VM. ATP-induced chondrocalcinosis. Arthritis Rheum 1992;35:1520-5.
25. Baldwin SA, Mackey JR, Cass CE, Young JD. Nucleoside transporters: molecular biology and implications for therapeutic development. Mol Med Today 1999;5:216-24.
26. Hyde RJ, Cass CE, Young JD, Baldwin SA. The ENT family of eukaryote nucleoside and nucleobase transporters: recent advances in the investigation of structure/function relationships and the identification of novel isoforms. Mol Membr Biol 2001;18:53-63.
27. Tesch AM, MacDonald MH, Kollias-Baker C, Benton HP. Effects of an adenosine kinase inhibitor and an adenosine deaminase inhibitor on accumulation of extracellular adenosine by equine articular chondrocytes. Am J Vet Res 2002;63:1512-9.
28. Kavanaugh MP, Kabat D. Identification and characterization of a widely expressed phosphate transporter/retrovirus receptor family. Kidney Int 1996;49:959-63.
29. Salaun C, Rodrigues P, Heard JM. Transmembrane topology of PiT-2, a phosphate transporter-retrovirus receptor. J Virol 2001;75:5584-92.
30. Palmer G, Zhao J, Bonjour J, Hofstetter W, Caverzasio J. In vivo expression of transcripts encoding the Glvr-1 phosphate transporter/retrovirus receptor during bone development. Bone 1999;24:1-7.
31. Palmer G, Guicheux J, Bonjour JP, Caverzasio J. Transforming growth factor-beta stimulates inorganic phosphate transport and expression of the type III phosphate transporter Glvr-1 in chondrogenic ATDC5 cells. Endocrinology 2000;141:2236-43.
32. Guicheux J, Palmer G, Shukunami C, Hiraki Y, Bonjour JP, Caverzasio J. A novel in vitro culture system for analysis of functional role of phosphate transport in endochondral ossification. Bone 2000;27:69-74.
33. Mansfield K, Teixeira CC, Adams CS, Shapiro IM. Phosphate ions mediate chondrocyte apoptosis through a plasma membrane transporter mechanism. Bone 2001;28:1-8.
34. Mansfield K, Rajpurohit R, Shapiro IM. Extracellular phosphate ions cause apoptosis of terminally differentiated epiphyseal chondrocytes. J Cell Physiol 1999;179:276-86.
35. Masuda I, Hirose J. Animal models of pathologic calcification. Curr Opin Rheumatol 2002;14:287-91.
36. Johnson K, Hashimoto S, Lotz M, Pritzker K, Goding J, Terkeltaub R. Up-regulated expression of the phosphodiesterase nucleotide pyrophosphatase family member PC-1 is a marker and pathogenic factor for knee meniscal cartilage matrix calcification. Arthritis Rheum 2001;44:1071-81.
37. Ryan LM. The ank gene story. Arthritis Res 2001;3:77-9.
38. Johnson K, van Etten D, Terkeltaub R. ANK and PC-1 regulate cartilage matrix calcification by synergistically controlling extracellular Ppi [abstract]. Arthritis Rheum 2001;44 Suppl 9:S162.
39. Rosenthal AK, Ryan LM. Probenecid inhibits transforming growth factor-beta 1 induced pyrophosphate elaboration by chondrocytes. J Rheumatol 1994;21:896-900.
40. Zimmermann H. Extracellular metabolism of ATP and other nucleotides. Naunyn Schmiedebergs Arch Pharmacol 2000;362:299-309.
41. Goding JW, Terkeltaub R, Maurice M, Deterre P, Sali A, Belli SI. Ecto-phosphodiesterase/pyrophosphatase of lymphocytes and non-lymphoid cells: structure and function of the PC-1 family. Immunol Rev 1998;161:11-26.
42. Stracke ML, Krutzsch HC, Unsworth EJ, Arestad A, Cioce V, Schiffmann E, et al. Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. J Biol Chem 1992;267:2524-9.
43. Lee HY, Murata J, Clair T, Polymeropoulos MH, Torres R, Manrow RE, et al. Cloning, chromosomal localization, and tissue expression of autotaxin from human teratocarcinoma cells. Biochem Biophys Res Commun 1996;218:714-9.
44. Narita M, Goji J, Nakamura H, Sano K. Molecular cloning, expression, and localization of a brain-specific phosphodiesterase I/nucleotide pyrophosphatase (PD-Ia) from rat brain. J Biol Chem 1994;269:28235-42.
45. Scott LJ, Delautier D, Meerson NR, Trugnan G, Goding JW, Maurice M. Biochemical and molecular identification of distinct forms of alkaline phosphodiesterase I expressed on the apical and basolateral plasma membrane surfaces of rat hepatocytes. Hepatology 1997;25:995-1002.
46. Gijsbers R, Ceulemans H, Stalmans W, Bollen M. Structural and catalytic similarities between nucleotide pyrophosphatases/phosphodiesterases and alkaline phosphatases. J Biol Chem 2001;276:1361-8.
47. Rutsch F, Vaingankar S, Johnson K, Goldfine I, Maddux B, Schauerte P, et al. PC-1 nucleoside triphosphate pyrophosphohydrolase deficiency in idiopathic infantile arterial calcification. Am J Pathol 2001;158:543-54.
48. Johnson K, Vaingankar S, Chen Y, Moffa A, Goldring MB, Sano K, et al. Differential mechanisms of inorganic pyrophosphate production by plasma cell membrane glycoprotein-1 and B10 in chondrocytes. Arthritis Rheum 1999;42:1986-97.
49. Rosenthal AK, Cheung HS, Ryan LM. Transforming growth factor β1 stimulates inorganic pyrophosphate elaboration by porcine cartilage. Arthritis Rheum 1991;34:904-11.
50. Cardenal A, Masuda I, Haas AL, McCarty DJ. Specificity of a porcine 127-kd nucleotide pyrophosphohydrolase for articular tissues. Arthritis Rheum 1996;39:245-51.
51. Johnson KA, Hessle L, Vaingankar S, Wennberg C, Mauro S, Narisawa S, et al. Osteoblast tissue-nonspecific alkaline phosphatase antagonizes and regulates PC-1. Am J Physiol 2000;279: R1365-77.
52. Lotz M, Rosen F, McCabe G, Quach J, Blanco F, Dudler J, et al. Interleukin 1 beta suppresses transforming growth factor-induced inorganic pyrophosphate (PPi) production and expression of the PPi-generating enzyme PC-1 in human chondrocytes. Proc Natl Acad Sci U S A 1995;92:10364-8.
53. Huang R, Rosenbach M, Vaughn R, Provvedini D, Rebbe N, Hickman S, et al. Expression of the murine plasma cell nucleotide pyrophosphohydrolase PC-1 is shared by human liver, bone, and cartilage cells. Regulation of PC-1 expression in osteosarcoma cells by transforming growth factor-beta. J Clin Invest 1994;94:560-7.
54. Masuda I, Cardenal A, Ono W, Hamada J, Haas AL, McCarty DJ. Nucleotide pyrophosphohydrolase in human synovial fluid. J Rheumatol 1997;24:1588-94.
55. Masuda I, Hamada J, Haas AL, Ryan LM, McCarty DJ. A unique ectonucleotide pyrophosphohydrolase associated with porcine chondrocyte-derived vesicles. J Clin Invest 1995;95:699-704.
56. Masuda I, Iyama KI, Halligan BD, Barbieri JT, Haas AL, McCarty DJ, et al. Variations in site and levels of expression of chondrocyte nucleotide pyrophosphohydrolase with aging. J Bone Miner Res 2001;16:868-75.
57. Lorenzo P, Neame P, Sommarin Y, Heinegard D. Cloning and deduced amino acid sequence of a novel cartilage protein (CILP) identifies a proform including a nucleotide pyrophosphohydrolase. J Biol Chem 1998;273:23469-75.
58. Van Hoof VO, De Broe ME. Interpretation and clinical significance of alkaline phosphatase isoenzyme patterns. Crit Rev Clin Lab Sci 1994;31:197-293.
59. Hoshi K, Amizuka N, Oda K, Ikehara Y, Ozawa H. Immunolocalization of tissue non-specific alkaline phosphatase in mice. Histochem Cell Biol 1997;107:183-91.
60. Rees JA, Ali SY. Ultrastructural localisation of alkaline phosphatase activity in osteoarthritic human articular cartilage. Ann Rheum Dis 1988;47:747-53.
61. Whyte MP, Landt M, Ryan LM, Mulivor RA, Henthorn PS, Fedde KN, et al. Alkaline phosphatase: placental and tissue-nonspecific isoenzymes hydrolyze phosphoethanolamine, inorganic pyrophosphate, and pyridoxal 5′-phosphate. Substrate accumulation in carriers of hypophosphatasia corrects during pregnancy. J Clin Invest 1995;95:1440-5.
62. Poelstra K, Bakker WW, Klok PA, Hardonk MJ, Meijer DK. A physiologic function for alkaline phosphatase: endotoxin detoxification. Lab Invest 1997;76:319-27.
63. Harada M, Udagawa N, Fukasawa K, Hiraoka BY, Mogi M. Inorganic pyrophosphatase activity of purified bovine pulp alkaline phosphatase at physiological pH. J Dent Res 1986;65:125-7.
64. Xu Y, Cruz TF, Pritzker KP. Alkaline phosphatase dissolves calcium pyrophosphate dihydrate crystals. J Rheumatol 1991;18:1606-10.
65. Whyte MP. Hypophosphatasia and the role of alkaline phosphatase in skeletal mineralization. Endocr Rev 1994;15:439-61.
66. Anderson HC, Hsu HH, Morris DC, Fedde KN, Whyte MP. Matrix vesicles in osteomalacic hypophosphatasia bone contain apatite-like mineral crystals. Am J Pathol 1997;151:1555-61.
67. Sevigny J, Picher M, Grondin G, Beaudoin AR. Purification and immunohistochemical localization of the ATP diphosphohydrolase in bovine lungs. Am J Physiol 1997;272:L939-50.
68. Van Rompay AR, Johansson M, Karlsson A. Phosphorylation of nucleosides and nucleoside analogs by mammalian nucleoside monophosphate kinases. Pharmacol Ther 2000;87:189-98.
69. Lacombe ML, Milon L, Munier A, Mehus JG, Lambeth DO. The human Nm23/nucleoside diphosphate kinases. J Bioenerg Biomembr 2000;32:247-58.
70. Lazarowski ER, Homolya L, Boucher RC, Harden TK. Identification of an ecto-nucleoside diphosphokinase and its contribution to interconversion of P2 receptor agonists. J Biol Chem 1997;272:20402-7.
71. Lazarowski ER, Boucher RC. UTP as an extracellular signaling molecule. News Physiol Sci 2001;16:1-5.
72. Donaldson SH, Picher M, Boucher RC. Secreted and cell-associated adenylate kinase and nucleoside diphosphokinase contribute to extracellular nucleotide metabolism on human airway surfaces. Am J Respir Cell Mol Biol 2002;26:209-15.
73. Picher M, Boucher RC. Human airway ecto-adenylate kinase: a mechanism to propagate ATP signaling on airway surfaces. J Biol Chem 2003;278:11256-64.
74. Wortmann RL, Ryan LM. Biological variation of rabbit chondrocyte 5′nucleotidase. Proc Soc Exp Biol Med 1983;173:349-54.
75. Bohn WW, Stein RM, Hsu HH, Morris DC, Anderson HC. Isolation of a plasma membrane-enriched fraction from collagenase-suspended rachitic rat growth plate chondrocytes. J Orthop Res 1984;1:319-24.
76. Greenberg CS, Birckbichler PJ, Rice RH. Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues. FASEB J 1991;5:3071-7.
77. Aeschlimann D, Thomazy V. Protein crosslinking in assembly and remodelling of extracellular matrices: the role of transglutaminases. Connect Tissue Res 2000;41:1-27.
78. Rosenthal AK, Derfus BA, Henry LA. Transglutaminase activity in aging articular chondrocytes and articular cartilage vesicles. Arthritis Rheum 1997;40:966-70.
79. Rosenthal AK, Masuda I, Gohr CM, Derfus BA, Le M. The transglutaminase, factor XIIIA, is present in articular chondrocytes. Osteoarthritis Cartilage 2001;9:578-81.
80. Johnson K, Hashimoto S, Lotz M, Pritzker K, Terkeltaub R. Interleukin-1 induces pro-mineralizing activity of cartilage tissue transglutaminase and factor XIIIa. Am J Pathol 2001;159:149-63.
81. Summey BT Jr, Graff RD, Lai TS, Greenberg CS, Lee GM. Tissue transglutaminase localization and activity regulation in the extracellular matrix of articular cartilage. J Orthop Res 2002;20:76-82.
82. Lai TS, Slaughter TF, Peoples KA, Hettasch JM, Greenberg CS. Regulation of human tissue transglutaminase function by magnesium-nucleotide complexes. Identification of distinct binding sites for Mg-GTP and Mg-ATP. J Biol Chem 1998;273:1776-81.
83. Lee KN, Arnold SA, Birckbichler PJ, Patterson MK Jr, Fraij BM, Takeuchi Y, et al. Site-directed mutagenesis of human tissue transglutaminase: Cys-277 is essential for transglutaminase activity but not for GTPase activity. Biochim Biophys Acta 1993;1202:1-6.
84. Lai TS, Slaughter TF, Koropchak CM, Haroon ZA, Greenberg CS. C-terminal deletion of human tissue transglutaminase enhances magnesium-dependent GTP/ATPase activity. J Biol Chem 1996;271:31191-5.
85. Nakano S, Ikata T, Kinoshita I, Kanematsu J, Yasuoka S. Characteristics of the protease activity in synovial fluid from patients with rheumatoid arthritis and osteoarthritis. Clin Exp Rheumatol 1999;17:161-70.
86. Rosenthal AK, Gohr CM, Heinkel DR. Thrombin increases transglutaminase activity in articular chondrocytes [abstract]. Arthritis Rheum 2001;44 Suppl 9:S64.
87. Kubler D, Pyerin W, Kinzel V. Assays of cell surface protein kinase: importance of selecting cytophilic substrates. Eur J Cell Biol 1982;26:306-9.
88. Kubler D, Pyerin W, Bill O, Hotz A, Sonka J, Kinzel V. Evidence for ecto-protein kinase activity that phosphorylates kemptide in a cyclic AMP-dependent mode. J Biol Chem 1989;264:14549-55.
89. Redegeld FA, Caldwell CC, Sitkovsky MV. Ecto-protein kinases: ecto-domain phosphorylation as a novel target for pharmacological manipulation? Trends Pharmacol Sci 1999;20:453-9.
90. Imada S, Sugiyama Y, Imada M. Fibronectin phosphorylation by ecto-protein kinase. Exp Cell Res 1988;179:554-64.
91. Seger D, Gechtman Z, Shaltiel S. Phosphorylation of vitronectin by casein kinase II. Identification of the sites and their promotion of cell adhesion and spreading. J Biol Chem 1998;273:24805-13.
92. Zhu X, Luo C, Ferrier JM, Sodek J. Evidence of ectokinase-mediated phosphorylation of osteopontin and bone sialoprotein by osteoblasts during bone formation in vitro. Biochem J 1997;323:637-43.
93. Hunter GK, Hauschka PV, Poole AR, Rosenberg LC, Goldberg HA. Nucleation and inhibition of hydroxyapatite formation by mineralized tissue proteins. Biochem J 1996;317:59-64.
94. Jono S, Peinado C, Giachelli CM. Phosphorylation of osteopontin is required for inhibition of vascular smooth muscle cell calcification. J Biol Chem 2000;275:20197-203.
95. Attur MG, Dave MN, Clancy RM, Patel IR, Abramson SB, Amin AR. Functional genomic analysis in arthritis-affected cartilage: yin-yang regulation of inflammatory mediators by alpha 5 beta 1 and alpha V beta 3 integrins. J Immunol 2000;164:2684-91.
96. Goding JW. Ecto-enzymes: physiology meets pathology. J Leukoc Biol 2000;67:285-311.
97. Fedde KN, Blair L, Silverstein J, Coburn SP, Ryan LM, Weinstein RS, et al. Alkaline phosphatase knock-out mice recapitulate the metabolic and skeletal defects of infantile hypophosphatasia. J Bone Miner Res 1999;14:2015-26.
98. Hessle L, Johnson KA, Anderson HC, Narisawa S, Sali A, Goding JW, et al. Tissue-nonspecific alkaline phosphatase and plasma cell membrane glycoprotein-1 are central antagonistic regulators of bone mineralization. Proc Natl Acad Sci U S A 2002;99:9445-9.
99. Altman RD, Muniz OE, Pita JC, Howell DS. Articular chondrocalcinosis: microanalysis of pyrophosphate (PPi) in synovial fluid and plasma. Arthritis Rheum 1973;16:171-8.
100. Silcox DC, McCarty DJ Jr. Elevated inorganic pyrophosphate concentrations in synovial fluids in osteoarthritis and pseudogout. J Lab Clin Med 1974;83:518-31.
101. Rachow JW, Ryan LM, McCarty DJ, Halverson PC. Synovial fluid inorganic pyrophosphate concentration and nucleotide pyrophosphohydrolase activity in basic calcium phosphate deposition arthropathy and Milwaukee shoulder syndrome. Arthritis Rheum 1988;31:408-13.
102. Johnson KA, Hay CW, Chu Q, Roe SC, Caterson B. Cartilage-derived biomarkers of osteoarthritis in synovial fluid of dogs with naturally acquired rupture of the cranial cruciate ligament. Am J Vet Res 2002;63:775-81.
103. Howell DS, Muniz O, Pita JC, Enis JE. Extrusion of pyrophosphate into extracellular media by osteoarthritic cartilage incubates. J Clin Invest 1975;56:1473-8.
104. Ryan LM, Cheung HS, McCarty DJ. Release of pyrophosphate by normal mammalian articular hyaline and fibrocartilage in organ culture. Arthritis Rheum 1981;24:1522-7.
105. Rosenthal AK. Formation of calcium pyrophosphate crystals: biologic implications. Curr Opin Rheumatol 2000;12:219-22.
106. Ryan LM, Rachow JW, McCarty DJ. Synovial fluid ATP: a potential substrate for the production of inorganic pyrophosphate. J Rheumatol 1991;18:716-20.
107. Park W, Masuda I, Cardenal-Escarcena A, Palmer DL, McCarty DJ. Inorganic pyrophosphate generation from adenosine triphosphate by cell-free human synovial fluid. J Rheumatol 1996;23:665-71.
108. Rachow JW, Ryan LM. Adenosine triphosphate pyrophosphohydrolase and neutral inorganic pyrophosphatase in pathologic joint fluids: elevated pyrophosphohydrolase in calcium pyrophosphate dihydrate crystal deposition disease. Arthritis Rheum 1985;28:1283-8.
109. Fuller CJ, Barr AR, Sharif M, Dieppe PA. Cross-sectional comparison of synovial fluid biochemical markers in equine osteoarthritis and the correlation of these markers with articular cartilage damage. Osteoarthritis Cartilage 2001;9:49-55.
110. Nanke Y, Kotake S, Akama H, Kamatani N. Alkaline phosphatase in rheumatoid arthritis patients: possible contribution of bone-type ALP to the raised activities of ALP in rheumatoid arthritis patients. Clin Rheumatol 2002;21:198-202.
111. Derfus B, Kranendonk S, Camacho N, Mandel N, Kushnaryov V, Lynch K, et al. Human osteoarthritic cartilage matrix vesicles generate both calcium pyrophosphate dihydrate and apatite in vitro. Calcif Tissue Int 1998;63:258-62.
112. Tenenbaum J, Muniz O, Schumacher HR, Good AE, Howell DS. Comparison of phosphohydrolase activities from articular cartilage in calcium pyrophosphate deposition disease and primary osteoarthritis. Arthritis Rheum 1981;24:492-500.
113. Einhorn TA, Gordon SL, Siegel SA, Hummel CF, Avitable MJ, Carty RP. Matrix vesicle enzymes in human osteoarthritis. J Orthop Res 1985;3:160-9.
114. Miao D, Scutt A. Histochemical localization of alkaline phosphatase activity in decalcified bone and cartilage. J Histochem Cytochem 2002;50:333-40.
115. Kouri JB, Aguilera JM, Reyes J, Lozoya KA, Gonzalez S. Apoptotic chondrocytes from osteoarthrotic human articular cartilage and abnormal calcification of subchondral bone. J Rheumatol 2000;27:1005-19.
116. Hirose J, Ryan LM, Masuda I. Up-regulated expression of cartilage intermediate-layer protein and ANK in articular hyaline cartilage from patients with calcium pyrophosphate dihydrate crystal deposition disease. Arthritis Rheum 2002;46:3218-29.
117. Johnson K, Pritzker K, Goding J, Terkeltaub R. The nucleoside triphosphate pyrophosphohydrolase isozyme PC-1 directly promotes cartilage calcification through chondrocyte apoptosis and increased calcium precipitation by mineralizing vesicles. J Rheumatol 2001;28:2681-91.
118. Lorenzo P, Bayliss MT, Heinegard D. A novel cartilage protein (CILP) present in the mid-zone of human articular cartilage increases with age. J Biol Chem 1998;273:23463-8.
119. Yamakawa K, Iwasaki H, Masuda I, Ohjimi Y, Honda I, Iyama K, et al. Cartilage intermediate layer protein expression in calcium pyrophosphate dihydrate crystal deposition disease. J Rheumatol 2002;29:1746-53.
120. Sohn P, Crowley M, Slattery E, Serra R. Developmental and TGF-beta-mediated regulation of Ank mRNA expression in cartilage and bone. Osteoarthritis Cartilage 2002;10:482-90.
121. Fahlgren A, Andersson B, Messner K. TGF-beta1 as a prognostic factor in the process of early osteoarthrosis in the rabbit knee. Osteoarthritis Cartilage 2001;9:195-202.
122. Fava R, Olsen N, Keski-Oja J, Moses H, Pincus T. Active and latent forms of transforming growth factor beta activity in synovial effusions. J Exp Med 1989;169:291-6.
123. Olmez U, Ryan LM, Kurup IV, Rosenthal AK. Insulin-like growth factor-1 suppresses pyrophosphate elaboration by transforming growth factor beta1-stimulated chondrocytes and cartilage. Osteoarthritis Cartilage 1994;2:149-54.
124. Fortier LA, Mohammed HO, Lust G, Nixon AJ. Insulin-like growth factor-I enhances cell-based repair of articular cartilage. J Bone Joint Surg Br 2002;84:276-88.
125. Van Beuningen HM, Glansbeek HL, van der Kraan PM, van den Berg WB. Osteoarthritis-like changes in the murine knee joint resulting from intra-articular transforming growth factor-beta injections. Osteoarthritis Cartilage 2000;8:25-33.
126. Derfus BA, Camacho NP, Olmez U, Kushnaryov VM, Westfall PR, Ryan LM, et al. Transforming growth factor beta-1 stimulates articular chondrocyte elaboration of matrix vesicles capable of greater calcium pyrophosphate precipitation. Osteoarthritis Cartilage 2001;9:189-94.
127. Rosen F, McCabe G, Quach J, Solan J, Terkeltaub R, Seegmiller JE, et al. Differential effects of aging on human chondrocyte responses to transforming growth factor β: increased pyrophosphate production and decreased cell proliferation. Arthritis Rheum 1997;40:1275-81.
128. Hirose J, Masuda I, Ryan LM. Expression of cartilage intermediate layer protein/nucleotide pyrophosphohydrolase parallels the production of extracellular inorganic pyrophosphate in response to growth factors and with aging. Arthritis Rheum 2000;43:2703-11.
129. Jones AC, Chuck AJ, Arie EA, Green DJ, Doherty M. Diseases associated with calcium pyrophosphate deposition disease. Semin Arthritis Rheum 1992;22:188-202.
130. Kohno H, Shigeno C, Kasai R, Akiyama H, Iida H, Tsuboyama T, et al. Synovial fluids from patients with osteoarthritis and rheumatoid arthritis contain high levels of parathyroid hormone-related peptide. J Bone Miner Res 1997;12:847-54.
131. Okano K, Tsukazaki T, Ohtsuru A, Osaki M, Yonekura A, Iwasaki K, et al. Expression of parathyroid hormone-related peptide in human osteoarthritis. J Orthop Res 1997;15:175-80.
132. Terkeltaub R, Lotz M, Johnson K, Deng D, Hashimoto S, Goldring MB, et al. Parathyroid hormone-related protein is abundant in osteoarthritic cartilage, and the parathyroid hormone-related protein 1-173 isoform is selectively induced by transforming growth factor β in articular chondrocytes and suppresses generation of extracellular inorganic pyrophosphate. Arthritis Rheum 1998;41:2152-64.
133. Goomer RS, Johnson KA, Burton DW, Amiel D, Maris TM, Gurjal A, et al. The tetrabasic KKKK(147-150) motif determines intracrine regulatory effects of PthrP 1-173 on chondrocyte PPi metabolism and matrix synthesis. Endocrinology 2000;141:4613-22.
134. Hedbom E, Hauselmann HJ. Molecular aspects of pathogenesis in osteoarthritis: the role of inflammation. Cell Mol Life Sci 2002;59:45-53.
135. Oehler S, Neureiter D, Meyer-Scholten C, Aigner T. Subtyping of osteoarthritic synoviopathy. Clin Exp Rheumatol 2002;20:633-40.
136. Melchiorri C, Meliconi R, Frizziero L, Silvestri T, Pulsatelli L, Mazzetti I, et al. Enhanced and coordinated in vivo expression of inflammatory cytokines and nitric oxide synthase by chondrocytes from patients with osteoarthritis. Arthritis Rheum 1998;41:2165-74.
137. Horiuchi T, Yoshida T, Koshihara Y, Sakamoto H, Kanai H, Yamamoto S, et al. The increase of parathyroid hormone-related peptide and cytokine levels in synovial fluid of elderly rheumatoid arthritis and osteoarthritis. Endocr J 1999;46:643-9.
138. Goldring MB. The role of cytokines as inflammatory mediators in osteoarthritis: lessons from animal models. Connect Tissue Res 1999;40:1-11.
139. Lotz M, Blanco FJ, von Kempis J, Dudler J, Maier R, Villiger PM, et al. Cytokine regulation of chondrocyte functions. J Rheumatol Suppl 1995;43:104-8.
140. Livne E, Laufer D, Blumenfeld I. Osteoarthritis in the temporo-mandibular joint (TMJ) of aged mice and the in vitro effect of TGF-beta 1 on cell proliferation, matrix synthesis, and alkaline phosphatase activity. Microsc Res Tech 1997;37:314-23.
141. Dubyak GR, el-Moatassim C. Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides. Am J Physiol 1993;265:C577-606.
142. Abbracchio MP, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C, Miras-Portugal MT, et al. Characterization of the UDP-glucose receptor (re-named here the P2Y(14) receptor) adds diversity to the P2Y receptor family. Trends Pharmacol Sci 2003;24:52-5.
143. North RA, Surprenant A. Pharmacology of cloned P2X receptors. Annu Rev Pharmacol Toxicol 2000;40:563-80.
144. Caswell AM, Leong WS, Russell RG. Evidence for the presence of P2-purinoceptors at the surface of human articular chondrocytes in monolayer culture. Biochim Biophys Acta 1991;1074:151-8.
145. 2+ waves in ATP-stimulated articular chondrocytes. J Bone Miner Res 1996;11:946-54.
146. D'Andrea P, Calabrese A, Grandolfo M. Intercellular calcium signaling between chondrocytes and synovial cells in co-culture. J Biochem 1998;329:681-7.
147. 2+ signaling in human chondrons cultured in three-dimensional agarose films. Osteoarthritis Cartilage 2001;9:518-26.
148. i and enhance basic fibroblast growth factor-induced proliferation in sheep chondrocytes. Endocrinology 1996;137:4757-66.
149. Koolpe M, Benton HP. Calcium-mobilizing purine receptors on the surface of mammalian articular chondrocytes. J Orthop Res 1997;15:204-12.
150. Leong WS, Russell RG, Caswell AM. Induction of enhanced responsiveness of human articular chondrocytes to extracellular ATP by tumour necrosis factor-alpha. Clin Sci (Lond) 1993;85:569-75.
151. Leong WS, Russell RG, Caswell AM. Stimulation of cartilage resorption by extracellular ATP acting at P2-purinoceptors. Biochim Biophys Acta 1994;1201:298-304.
152. Boeynaems JM, Communi D, Pirotton S, Motte S, Parmentier M. Involvement of distinct receptors in the actions of extracellular uridine nucleotides. Ciba Found Symp 1996;198:266-74.
153. Kennedy C. The discovery and development of P2 receptor subtypes. J Auton Nerv Syst 2000;81:158-63.
154. Hoebertz A, Townsend-Nicholson A, Glass R, Burnstock G, Arnett TR. Expression of P2 receptors in bone and cultured bone cells. Bone 2000;27:503-10.
155. Di Virgilio F, Chiozzi P, Ferrari D, Falzoni S, Sanz JM, Morelli A, et al. Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 2001;97:587-600.
156. Chakfe Y, Seguin R, Antel JP, Morissette C, Malo D, Henderson D, et al. ADP and AMP induce interleukin-1beta release from microglial cells through activation of ATP-primed P2X7 receptor channels. J Neurosci 2002;22:3061-9.
157. Imai M, Goepfert C, Kaczmarek E, Robson SC. CD39 modulates IL-1 release from activated endothelial cells. Biochem Biophys Res Commun 2000;270:272-8.
158. Brown CJ, Caswell AM, Rahman S, Russell RG, Buttle DJ. Proteoglycan breakdown from bovine nasal cartilage is increased, and from articular cartilage is decreased, by extracellular ATP. Biochim Biophys Acta 1997;1362:208-20.
159. Croucher LJ, Crawford A, Hatton PV, Russell RG, Buttle DJ. Extracellular ATP and UTP stimulate cartilage proteoglycan and collagen accumulation in bovine articular chondrocyte pellet cultures. Biochim Biophys Acta 2000;1502:297-306.
160. Beigi R, Kobatake E, Aizawa M, Dubyak GR. Detection of local ATP release from activated platelets using cell surface-attached firefly luciferase. Am J Physiol 1999;276:C267-78.
161. - channels. J Gen Physiol 1999;114:525-33.
162. Newman EA. Propagation of intercellular calcium waves in retinal astrocytes and Muller cells. J Neurosci 2001;21:2215-23.
163. Linden J. Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annu Rev Pharmacol Toxicol 2001;41:775-87.
164. 2 release. Arthritis Rheum 1999;42:258-67.
165. Tesch AM, MacDonald MH, Kollias-Baker C, Benton HP. Chondrocytes respond to adenosine via A2 receptors and activity is potentiated by an adenosine deaminase inhibitor and a phosphodiesterase inhibitor. Osteoarthritis Cartilage 2002;10:34-43.
166. Ohta A, Sitkovsky M. Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 2001;414:916-20.
167. Murakami S, Hashikawa T, Saho T, Takedachi M, Nozaki T, Shimabukuro Y, et al. Adenosine regulates the IL-1 beta-induced cellular functions of human gingival fibroblasts. Int Immunol 2001;13:1533-40.
168. Spychala J. Tumor-promoting functions of adenosine. Pharmacol Ther 2000;87:161-73.
169. Benton HP, MacDonald MH, Tesch AM. Effects of adenosine on bacterial
170. Wortmann RL, Veum JA, Rachow JW. Synovial fluid 5′-nucleotidase activity: relationship to other purine catabolic enzymes and to arthropathies associated with calcium crystal deposition. Arthritis Rheum 1991;34:1014-20.
171. Le Hir M, Kaissling B. Distribution and regulation of renal ecto-5′-nucleotidase: implications for physiological functions of adenosine. Am J Physiol 1993;264:F377-87.
172. Ryan LM, Kurup IV, Cheung HS. Transduction mechanisms of porcine chondrocyte inorganic pyrophosphate elaboration. Arthritis Rheum 1999;42:555-60.
173. Su S, DiBattista JA, Sun Y, Li WQ, Zafarullah M. Up-regulation of tissue inhibitor of metalloproteinases-3 gene expression by TGF-beta in articular chondrocytes is mediated by serine/threonine and tyrosine kinases. J Cell Biochem 1998;70:517-27.
174. Wright GD, Doherty M. Calcium pyrophosphate crystal deposition is not always 'wear and tear' or aging. Ann Rheum Dis 1997;56:586-8.
175. Tsui FWL, Tsui HW, Cheng EY, Stone M, Payne U, Reveille JD, et al. Novel genetic markers in the 5′-flanking region of ANKH are associated with ankylosing spondylitis. Arthritis Rheum 2003;48:791-7.
176. Munroe PB, Olgunturk RO, Fryns JP, van Maldergem L, Ziereisen F, Yuksel B, et al. Mutations in the gene encoding the human matrix Gla protein cause Keutel syndrome. Nat Genet 1999;21:142-4.
177. Becker MA. Clinical gout and the pathogenesis of hyperuricemia. In: Koopman WJ, editor. Arthritis and allied conditions. A textbook of rheumatology. Vol. 2. 14th ed. Philadelphia: Lippincott Williams & Wilkins; 2001. p. 2281-313.
178. Grobben B, Anciaux K, Roymans D, Stefan C, Bollen M, Esmans EL, et al. An ecto-nucleotide pyrophosphatase is one of the main enzymes involved in the extracellular metabolism of ATP in rat C6 glioma. J Neurochem 1999;72:826-34.
179. Picher M, Boucher RC. Biochemical evidence for an ecto alkaline phosphodiesterase I in human airways. Am J Respir Cell Mol Biol 2000;23:255-61.
180. Fedde KN, Lane CC, Whyte MP. Alkaline phosphatase is an ectoenzyme that acts on micromolar concentrations of natural substrates at physiologic pH in human osteosarcoma (SAOS-2) cells. Arch Biochem Biophys 1988;264:400-9.
181. Picher M, Burch LH, Hirsh AJ, Spychala J, Boucher RC. Ecto 5′-nucleotidase and non-specific alkaline phosphatase: two AMP-hydrolyzing ectoenzymes with distinct roles in human airways. J Biol Chem 2003;278:13468-79.
182. Cardenal A, Masuda I, Haas AL, Ono W, McCarty DJ. Identification of a nucleotide pyrophosphohydrolase from articular tissues in human serum. Arthritis Rheum 1996;39:252-6.
183. Zimmermann H. Extracellular purine metabolism. Drug Dev Res 1996;39:337-52.
184. Mateo J, Harden TK, Boyer JL. Functional expression of a CDNA encoding a human ecto-ATPase. Br J Pharmacol 1999;128:396-402.
185. Smith TM, Kirley TL. Site-directed mutagenesis of a human brain ecto-apyrase: evidence that the E-type ATPases are related to the actin/heat shock 70/sugar kinase superfamily. Biochemistry 1999;38:321-8.
186. Turnay J, Olmo N, Navarro JM, Gavilanes JG, Lizarbe MA. Isolation and characterization of the ecto-5′-nucleotidase from a rat glioblastoma cell line. Mol Cell Biochem 1992;117:23-33.
187. Le Hir M, Gandhi R, Dubach UC. Purification and properties of a 5′-nucleotidase from rat renal membranes. Enzyme 1989;41:87-93.
188. Chen XY, Lo TC. Involvement of a cell surface protein and an ecto-protein kinase in myogenesis. Biochem J 1991;279:475-82.
189. Yegutkin GG, Henttinen T, Jalkanen S. Extracellular ATP formation on vascular endothelial cells is mediated by ecto-nucleotide kinase activities via phosphotransfer reactions. FASEB J 2001;15:251-60.